Related references
Note: Only part of the references are listed.Association analysis of MALAT1 polymorphisms and risk of psoriasis among Iranian patients
Soudeh Ghafouri-Fard et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2022)
Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction
Tong Zhang et al.
BMC CARDIOVASCULAR DISORDERS (2022)
Association of seven fundamental genetic polymorphisms in long noncoding RNA MALAT1, SOX2OT and H19 with recurrent miscarriage in Turkish-Azeri Iranian population
Parvin Hakimi et al.
HUMAN GENE (2022)
Role of MALAT1 in gynecological cancers: Pathologic and therapeutic aspects
Feng-Hua Qiao et al.
ONCOLOGY LETTERS (2021)
Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer
Bela Goyal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer
Chuansheng Yang et al.
CURRENT CANCER DRUG TARGETS (2021)
tRNA-like leader-trailer interaction promotes 3′-end maturation of MALAT1
Seyed-Fakhreddin Torabi et al.
RNA (2021)
MALATI Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose
Chong Lu et al.
CLINICAL INTERVENTIONS IN AGING (2021)
Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma
Yi-Fang Ding et al.
FRONTIERS IN ONCOLOGY (2021)
Cancer stem cells: A review from origin to therapeutic implications
Mohammad Reza Atashzar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation
Ding-wen Cao et al.
ACTA PHARMACOLOGICA SINICA (2020)
Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140
Zhou-Hua Hou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
被撤回的出版物: Long non-coding RNA LINC00160 functions as a decoy of microRNA-132 to mediate autophagy and drug resistance in hepatocellular carcinoma via inhibition of PIK3R3 (Retracted article. See vol. 549, 2022)
Wei Zhang et al.
CANCER LETTERS (2020)
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells
Jingqiu Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer
Yun-Fei Zhang et al.
LIFE SCIENCES (2020)
MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin
Kitsada Kangboonruang et al.
ANTICANCER RESEARCH (2020)
lncRNA MALATI Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
Ran Wang et al.
ONCOTARGETS AND THERAPY (2020)
Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma
Lei Fan et al.
MOLECULAR CANCER THERAPEUTICS (2020)
LncRNA MALAT I Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
Qingqiang Dai et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Meta-analysis of the association betweenMALAT1rs619586 A>G polymorphism and cancer risk
Wenwen Ni et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1
Jinghua Huang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance via immunosuppressive miR-182/miR-217 signaling and p27/CDK6 regulation
Kalliopi Domvri et al.
Oncotarget (2020)
The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Sternness by Inhibiting YAP Translocation from Nucleus to Cytoplasm
XingMei Wu et al.
MEDICAL SCIENCE MONITOR (2020)
LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195
Qing-Ming Wang et al.
LIFE SCIENCES (2019)
Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer
Dongxin Tang et al.
CELLULAR SIGNALLING (2019)
Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia
Shahrzad Pouyanrad et al.
GENE (2019)
被撤回的出版物: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy (Retracted article. See vol. 18, pg. 1597, 2023)
Qiang Cai et al.
MOLECULAR CANCER (2019)
LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability
Yiwen Xiao et al.
FEBS OPEN BIO (2019)
Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity
Qi Yao et al.
FEBS OPEN BIO (2019)
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
Fan Sun et al.
NATURE COMMUNICATIONS (2019)
The contrary functions of lncRNA HOTAIR/miR-17-5p/PTEN axis and Shenqifuzheng injection on chemosensitivity of gastric cancer cells
Jianguang Jia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Chemotherapy for hepatocellular carcinoma: current status and future perspectives
Masafumi Ikeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim et al.
NUCLEIC ACIDS RESEARCH (2018)
Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKαNF-κB pathway
De-Gang Ji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation
Zhixian Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway
Lin Bai et al.
EXPERIMENTAL CELL RESEARCH (2018)
Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12
Dong Xue et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
Hsi-Hsien Hsu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma
Yi Hu et al.
LEUKEMIA (2018)
KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1
Haishan Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer
Qi Yang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia
Feng Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone et al.
FRONTIERS IN PHARMACOLOGY (2018)
Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
Nicoletta Colombo et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer
Hu YiRen et al.
MOLECULAR CANCER (2017)
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Y. Chang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
Jihong An et al.
ONCOTARGETS AND THERAPY (2017)
MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression
Wei Chen et al.
ONCOTARGET (2017)
Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity
Xiaona Chen et al.
CELL DISCOVERY (2017)
Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets
Zhihong Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide
Hongwei Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Autophagy and multidrug resistance in cancer
Ying-Jie Li et al.
CHINESE JOURNAL OF CANCER (2017)
The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy
Peng Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Long noncoding RNAs: Re-writing dogmas of RNA processing and stability
Jeremy E. Wilusz
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Natural antisense RNA promotes 3' end processing and maturation of MALAT1 lncRNA
Xinying Zong et al.
NUCLEIC ACIDS RESEARCH (2016)
Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer
Qingjuan Chen et al.
ONCOLOGY LETTERS (2016)
Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease
Yuting Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Broad targeting of resistance to apoptosis in cancer
Ramzi M. Mohammad et al.
SEMINARS IN CANCER BIOLOGY (2015)
Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex
Q. Ji et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting DNA damage response in cancer therapy
Noriko Hosoya et al.
CANCER SCIENCE (2014)
Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel Growth
Katharina M. Michalik et al.
CIRCULATION RESEARCH (2014)
Activation of LTBP3 Gene by a Long Noncoding RNA (lncRNA) MALAT1 Transcript in Mesenchymal Stem Cells from Multiple Myeloma
Bingzong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
J-Y Liu et al.
CELL DEATH & DISEASE (2014)
Cancer Stem Cells and Their Mechanism of Chemo-Radiation Resistance
Yonghyun Kim et al.
International Journal of Stem Cells (2014)
The Role of Epithelial Mesenchymal Transition Markers in Thyroid Carcinoma Progression
Celina Montemayor-Garcia et al.
ENDOCRINE PATHOLOGY (2013)
MALAT-1 interacts with hnRNP C in cell cycle regulation
Feng Yang et al.
FEBS LETTERS (2013)
Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas
Darya Buehler et al.
MODERN PATHOLOGY (2013)
Autophagy and disease: always two sides to a problem
Sunandini Sridhar et al.
JOURNAL OF PATHOLOGY (2012)
Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development
Moritz Eissmann et al.
RNA BIOLOGY (2012)
The lncRNA Malat1 Is Dispensable for Mouse Development but Its Transcription Plays a cis-Regulatory Role in the Adult
Bin Zhang et al.
CELL REPORTS (2012)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression
Delphine Bernard et al.
EMBO JOURNAL (2010)
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation
Vidisha Tripathi et al.
MOLECULAR CELL (2010)
Introduction to Cancer Chemotherapeutics
Donna S. Shewach et al.
CHEMICAL REVIEWS (2009)
An Architectural Role for a Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of Paraspeckles
Christine M. Clemson et al.
MOLECULAR CELL (2009)
3′ End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA
Jeremy E. Wilusz et al.
CELL (2008)
Autophagy in the pathogenesis of disease
Beth Levine et al.
CELL (2008)
Homologous recombination in DNA repair and DNA damage tolerance
Xuan Li et al.
CELL RESEARCH (2008)
The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons
Masamitsu Sone et al.
JOURNAL OF CELL SCIENCE (2007)
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains
John N. Hutchinson et al.
BMC GENOMICS (2007)
Caspase family proteases and apoptosis
TJ Fan et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2005)
Absence or low expression of Fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome
L Tourneur et al.
CANCER RESEARCH (2004)
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
P Ji et al.
ONCOGENE (2003)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
Share Paper
